| abstract |
A method of treating male Alzheimer's disease, Parkinson's disease, sexual dysfunction or erectile dysfunction by administering a 5α-reductase inhibitor with a testosterone supplement has been described. The method may also be used to treat male sexual dysfunction or erectile dysfunction, PDE V inhibitor, AGE (progressive glycation end product) breaker, alpha 1 blocker, alpha 1A antagonist, alpha 2 antagonist, dopamine agonist, dopamine 5α-reductase inhibitor compounds for use in combination with other drugs useful for the treatment of erectile dysfunction such as D4 agonists, melanocortin agonists, oxytocin agonists, prostaglandins, radical scavengers, rotamase inhibitors, aviptadil, nitroglycerin and GPCR agonists And the use of testosterone supplements. |